Signaling Pathways - CK1 - potassium channel - Angiotensin AT2 Receptors - RET
清除全部
- B2206 PD123319Target: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体的拮抗剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A3719 PF-670462Target: CK1Summary: CK1 ε/δ抑制剂
- A3704 PD 123319 ditrifluoroacetateTarget: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体拮抗剂
- A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂
- A3342 D44761 CitationTarget: CK1Summary: CK1/ALK5抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂